9vhpv Vaccine Is Indicated In Females 9 Years Of Age In The Prevention Of Cervical Vulvar Vaginal And Anal Cancer Precancerous Or Dysplastic Lesions And Persistent Infections Caused By Human Papillomavirus Hpv Types 16 18 31 33 45 52 And 58 And Genital Warts Condyloma Acuminata Caused By Hpv Types 6 And 11 clinical trials
Explore recruiting 9vhpv vaccine is indicated in females 9 years of age in the prevention of cervical vulvar vaginal and anal cancer precancerous or dysplastic lesions and persistent infections caused by human papillomavirus hpv types 16 18 31 33 45 52 and 58 and genital warts condyloma acuminata caused by hpv types 6 and 11 clinical trials.
Also recruiting in Europe
9vhpv Vaccine Is Indicated In Females 9 Years Of Age In The Prevention Of Cervical Vulvar Vaginal And Anal Cancer Precancerous Or Dysplastic Lesions And Persistent Infections Caused By Human Papillomavirus Hpv Types 16 18 31 33 45 52 And 58 And Genital Warts Condyloma Acuminata Caused By Hpv Types 6 And 11 trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.